In the area of dystonia treatment, we continue to provide botulinum toxin injections to our patients while training physicians to perform these injections. For patients with blepharospasm, we have evaluated the efficacy of various types of non-invasive brain stimulation. We have conducted therapeutic trials in blepharospasm of a cream that has an action similar to botulinum toxin, but we were not able to demonstrate efficacy. Past studies from our group have shown that certain rehabilitation techniques, such as motor training and sensory training can be therapeutic. We have initiated a new project combining botulinum toxin and rehabilitation that might be more efficacious. New treatments are needed for essential tremor. One promising agent is 1-octanol and its metabolite, 1-octanoic acid, which we continue to develop. We have characterized the pharmacokinetics and compared the efficacy of different formulations in a dose escalation and cross-over study in patients with essential tremor. Most recently, we have completed a study with 1-octanoic acid, seeking the maximum tolerated dose. We are working with a multi-center team to develop a trial of Cognitive Behavioral Therapy for functional movement disorders.

Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
2016
Total Cost
Indirect Cost
City
State
Country
Zip Code
Jinnah, H A; Comella, Cynthia L; Perlmutter, Joel et al. (2018) Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy? Toxicon 147:89-95
Lin, Peter T; Ross, Erika K; Chidester, Paula et al. (2018) Noninvasive neuromodulation in essential tremor demonstrates relief in a sham-controlled pilot trial. Mov Disord 33:1182-1183
Wagle Shukla, Aparna; Hu, Wei; Legacy, Joseph et al. (2018) Combined effects of rTMS and botulinum toxin therapy in benign essential blepharospasm. Brain Stimul 11:645-647
Hallett, Mark (2018) Mechanism of action of botulinum neurotoxin: Unexpected consequences. Toxicon 147:73-76
Klein, Max M; Treister, Roi; Raij, Tommi et al. (2016) Reply. Pain 157:1175-6
Vanegas-Arroyave, Nora; Lauro, Peter M; Huang, Ling et al. (2016) Tractography patterns of subthalamic nucleus deep brain stimulation. Brain 139:1200-10
Haubenberger, Dietrich; Abbruzzese, Giovanni; Bain, Peter G et al. (2016) Transducer-based evaluation of tremor. Mov Disord 31:1327-36
Simpson, David M; Hallett, Mark; Ashman, Eric J et al. (2016) Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 86:1818-26
Voller, Bernhard; Lines, Emily; McCrossin, Gayle et al. (2016) Dose-escalation study of octanoic acid in patients with essential tremor. J Clin Invest 126:1451-7
Rossi, P Justin; Gunduz, Aysegul; Judy, Jack et al. (2016) Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies. Front Neurosci 10:119

Showing the most recent 10 out of 49 publications